miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice

Journal of Experimental Medicine

Volumn 208, Issue 6, 2011, Pages 1189-1201

  Boldin, Mark P ^a,b,d   Taganov, Konstantin D ^a,b   Rao, Dinesh S ^a,c   Yang, Lili ^a   Zhao, Jimmy L ^a   Kalwani, Manorama ^a   Garcia Flores, Yvette ^a   Luong, Mui ^a   Devrekanli, Asli ^a   Xu, Jessica ^b   Sun, Guizhen ^b   Tay, Jia ^b   Linsley, Peter S ^b   Baltimore, David ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b REGULUS THERAPEUTICS   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 146A; MICRORNA 21; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CARCINOGENESIS; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENETIC ENGINEERING; IMMUNOCOMPETENT CELL; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL;

3' UNTRANSLATED REGIONS; ANIMALS; AUTOIMMUNITY; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICRORNAS; NEOPLASMS; RNA PROCESSING, POST-TRANSCRIPTIONAL; TNF RECEPTOR-ASSOCIATED FACTOR 6; UP-REGULATION;

EID: 79958257077     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20101823     Document Type: Article

References (53)

1. Aikawa, Y., T. Katsumoto, P. Zhang, H. Shima, M. Shino, K. Terui, E. Ito, H. Ohno, E.R. Stanley, H. Singh, et al. 2010. PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZTIF2. Nat. Med. 16:580-585: 1p: 585.
2. Ambros, V. 2004. The functions of animal microRNAs. Nature. 431:350-355.
3. Baek, D., J. Villén, C. Shin, F.D. Camargo, S.P. Gygi, and D.P. Bartel. 2008. The impact of microRNAs on protein output. Nature. 455:64-71.
4. Balkwill, F., and A. Mantovani. 2001. Inflammation and cancer: back to Virchow? Lancet. 357:539-545.
5. Baltimore, D., M.P. Boldin, R.M. O'Connell, D.S. Rao, and K.D. Taganov. 2008. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9:839-845.
6. Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281-297.
7. Bazzoni, F., M. Rossato, M. Fabbri, D. Gaudiosi, M. Mirolo, L. Mori, N. Tamassia, A. Mantovani, M.A. Cassatella, and M. Locati. 2009. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl. Acad. Sci. USA. 106:5282-5287.
8. Berglund, M., J.A. Thomas, E.H. Hörnquist, and O.H. Hultgren. 2008. Tolllike receptor cross-hyporesponsiveness is functional in interleukin-1-receptor-associated kinase-1 (IRAK-1)-deficient macrophages: differential role played by IRAK-1 in regulation of tumour necrosis factor and interleukin-10 production. Scand. J. Immunol. 67:473-479.
9. Bhaumik, D., G.K. Scott, S. Schokrpur, C.K. Patil, J. Campisi, and C.C. Benz. 2008. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene. 27:5643-5647.
10. Brown, B.D., B. Gentner, A. Cantore, S. Colleoni, M. Amendola, A. Zingale, A. Baccarini, G. Lazzari, C. Galli, and L. Naldini. 2007. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat. Biotechnol. 25:1457-1467.
11. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D.V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature. 383:443-446.
12. Chang, T.C., D. Yu, Y.S. Lee, E.A. Wentzel, D.E. Arking, K.M. West, C.V. Dang, A. Thomas-Tikhonenko, and J.T. Mendell. 2008. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40:43-50.
13. Choi, Y. 2005. Role of TRAF6 in the immune system. Adv. Exp. Med. Biol. 560:77-82.
14. Copeland, N.G., N.A. Jenkins, and D.L. Court. 2001. Recombineering: a powerful new tool for mouse functional genomics. Nat. Rev. Genet. 2:769-779.
15. Coussens, L.M., and Z. Werb. 2002. Inflammation and cancer. Nature. 420:860-867.
16. Dale, E., M. Davis, and D.L. Faustman. 2006. A role for transcription factor NF-kappaB in autoimmunity: possible interactions of genes, sex, and the immune response. Adv. Physiol. Educ. 30:152-158.
17. Deng, C., C. Radu, A. Diab, M.F. Tsen, R. Hussain, J.S. Cowdery, M.K. Racke, and J.A. Thomas. 2003. IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity. J. Immunol. 170:2833-2842.
18. Friberg, C., K. Björck, S. Nilsson, A. Inerot, J. Wahlström, and L. Samuelsson. 2006. Analysis of chromosome 5q31-32 and psoriasis: confirmation of a susceptibility locus but no association with SNPs within SLC22A4 and SLC22A5. J. Invest. Dermatol. 126:998-1002.
19. Gisselbrecht, S., S. Fichelson, B. Sola, D. Bordereaux, A. Hampe, C. André, F. Galibert, and P. Tambourin. 1987. Frequent c-fms activation by proviral insertion in mouse myeloblastic leukaemias. Nature. 329:259-261.
20. Gu, T.L., T. Mercher, J.W. Tyner, V.L. Goss, D.K. Walters, M.G. Cornejo, C. Reeves, L. Popova, K. Lee, M.C. Heinrich, et al. 2007. A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia. Blood. 110:323-333.
21. Hurst, D.R., M.D. Edmonds, G.K. Scott, C.C. Benz, K.S. Vaidya, and D.R. Welch. 2009. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 69:1279-1283.
22. Ishida, T., S. Mizushima, S. Azuma, N. Kobayashi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, et al. 1996. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271:28745-28748.
23. Johnnidis, J.B., M.H. Harris, R.T. Wheeler, S. Stehling-Sun, M.H. Lam, O. Kirak, T.R. Brummelkamp, M.D. Fleming, and F.D. Camargo. 2008. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 451:1125-1129.
24. Karin, M. 2006. Nuclear factor-kappaB in cancer development and progression. Nature. 441:431-436.
25. Karincaoglu, Y., E. Kaya, M. Esrefoglu, and I. Aydogdu. 2003. Development of large genital ulcer due to hydroxyurea treatment in a patient with chronic myeloid leukemia and Behcet's disease. Leuk. Lymphoma. 44:1063-1065.
26. Kauppi, P., K. Lindblad-Toh, P. Sevon, H.T. Toivonen, J.D. Rioux, A. Villapakkam, L.A. Laitinen, T.J. Hudson, J. Kere, and T. Laitinen. 2001. A second-generation association study of the 5q31 cytokine gene cluster and the interleukin-4 receptor in asthma. Genomics. 77:35-42.
27. Kobayashi, T., P.T. Walsh, M.C. Walsh, K.M. Speirs, E. Chiffoleau, C.G. King, W.W. Hancock, J.H. Caamano, C.A. Hunter, P. Scott, et al. 2003. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity. 19:353-363.
28. Landgraf, P., M. Rusu, R. Sheridan, A. Sewer, N. Iovino, A. Aravin, S. Pfeffer, A. Rice, A.O. Kamphorst, M. Landthaler, et al. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 129:1401-1414.
29. Li, L., S. Cousart, J. Hu, and C.E. McCall. 2000. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J. Biol. Chem. 275:23340-23345.
30. Li, X., M. Commane, Z. Jiang, and G.R. Stark. 2001. IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptorassociated kinase (IRAK). Proc. Natl. Acad. Sci. USA. 98:4461-4465.
31. Liew, F.Y., D. Xu, E.K. Brint, and L.A. O'Neill. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5:446-458.
32. Lin, S.L., A. Chiang, D. Chang, and S.Y. Ying. 2008. Loss of mir-146a function in hormone-refractory prostate cancer. RNA. 14:417-424.
33. Liu, G., A. Friggeri, Y. Yang, Y.J. Park, Y. Tsuruta, and E. Abraham. 2009. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc. Natl. Acad. Sci. USA. 106:15819-15824.
34. Lois, C., E.J. Hong, S. Pease, E.J. Brown, and D. Baltimore. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science. 295:868-872.
35. Lomaga, M.A., W.C. Yeh, I. Sarosi, G.S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman, et al. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1015-1024.
36. Lu, L.-F., M.P. Boldin, A. Chaudhry, L.-L. Lin, K.D. Taganov, T. Hanada, A. Yoshimura, D. Baltimore, and A.Y. Rudensky. 2010. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell. 142:914-929.
37. Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. 2008. Cancer-related inflammation. Nature. 454:436-444.
38. Nahid, M.A., K.M. Pauley, M. Satoh, and E.K. Chan. 2009. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J. Biol. Chem. 284:34590-34599.
39. Naito, A., S. Azuma, S. Tanaka, T. Miyazaki, S. Takaki, K. Takatsu, K. Nakao, K.Nakamura, M. Katsuki, T. Yamamoto, and J. Inoue. 1999. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells. 4:353-362.
40. O'Connell, R.M., D.S. Rao, A.A. Chaudhuri, M.P. Boldin, K.D. Taganov, J. Nicoll, R.L. Paquette, and D. Baltimore. 2008. Sustained expression ofmicroRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 205:585-594.
41. Perry, M.M., S.A. Moschos, A.E. Williams, N.J. Shepherd, H.M. Larner-Svensson, and M.A. Lindsay. 2008. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J. Immunol. 180:5689-5698.
42. Rambaldi, A., N. Wakamiya, E. Vellenga, J. Horiguchi, M.K. Warren, D. Kufe, and J.D. Griffin. 1988. Expression of the macrophage colony-stimulating factor and c-fms genes in human acute myeloblastic leukemia cells. J. Clin. Invest. 81:1030-1035.
43. Rioux, J.D., M.J. Daly, M.S. Silverberg, K. Lindblad, H. Steinhart, Z. Cohen, T. Delmonte, K. Kocher, K. Miller, S. Guschwan, et al. 2001. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29:223-228.
44. Rodriguez, A., E. Vigorito, S. Clare, M.V. Warren, P. Couttet, D.R. Soond, S. van Dongen, R.J. Grocock, P.P. Das, E.A. Miska, et al. 2007. Requirement of bic/microRNA-155 for normal immune function. Science. 316:608-611.
45. Sheedy, F.J., E. Palsson-McDermott, E.J. Hennessy, C. Martin, J.J. O'Leary, Q. Ruan, D.S. Johnson, Y. Chen, and L.A. O'Neill. 2010. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11:141-147.
46. Starczynowski, D.T., F. Kuchenbauer, B. Argiropoulos, S. Sung, R. Morin, A. Muranyi, M. Hirst, D. Hogge, M. Marra, R.A. Wells, et al. 2010. Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype. Nat. Med. 16:49-58.
47. Taganov, K.D., M.P. Boldin, K.J. Chang, and D. Baltimore. 2006. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA. 103:12481-12486.
48. Thirman, M.J., and R.A. Larson. 1996. Therapy-related myeloid leukemia. Hematol. Oncol. Clin. North Am. 10:293-320.
49. Tokuhiro, S., R. Yamada, X. Chang, A. Suzuki, Y. Kochi, T. Sawada, M. Suzuki, M. Nagasaki, M. Ohtsuki, M. Ono, et al. 2003. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35:341-348.
50. Tsitsiou, E., and M.A. Lindsay. 2009. microRNAs and the immune response. Curr. Opin. Pharmacol. 9:514-520.
51. van Dongen, S., C. Abreu-Goodger, and A.J. Enright. 2008. Detecting microRNA binding and siRNA off-target effects from expression data. Nat. Methods. 5:1023-1025.
52. Wang, C., C.A. Kelleher, G.Y. Cheng, J. Miyauchi, G.G. Wong, S.C. Clark, M.D. Minden, and E.A. McCulloch. 1988. Expression of the CSF-1 gene in the blast cells of acute myeloblastic leukemia: association with reduced growth capacity. J. Cell. Physiol. 135:133-138.
53. Xia, H., Y. Qi, S.S. Ng, X. Chen, D. Li, S. Chen, R. Ge, S. Jiang, G. Li, Y. Chen, et al. 2009. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res. 1269:158-165.